Martin Yudovich
Pediatrics · Houston, TXNPI 1285799890
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $20,000 of the $23,997 with a category attached, or 83.3%. Pfizer accounts for 84.4% of it on its own, with 27 other manufacturers making up the rest. 2025 is the largest year on record at $20,929, more than ten times the $757 reported in 2019. Among pediatrics clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 97 payments — averaging $247.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$20K
- GSK$612
- Abbott$259
- Ironshore Pharmaceuticals Inc.$239
- Sanofi Pasteur Inc.$217
- Merck$212
- plus $2K from 22 others
Across 725 payments — averaging $6074.99 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Sanofi Pasteur Inc.$1.8M
- Pfizer$799K
- Merck$545K
- Novavax Inc$461K
- Genentech, Inc.$387K
- Modernatx, Inc.$181K
- plus $266K from 5 others
What the payments were for
- Consulting fees$20,00083%
- Travel & lodging$2231%
- Food & beverage$3,77516%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 4 | $20,265 |
| GSK | 16 | $612 |
| Abbott | 2 | $259 |
| Ironshore Pharmaceuticals Inc. | 3 | $239 |
| Sanofi Pasteur Inc. | 6 | $217 |
| Merck | 12 | $212 |
| AstraZeneca(2 entities) | 4 | $192 |
| Biogen | 2 | $180 |
| Sanofi | 2 | $165 |
| Cranial Technologies, Inc | 12 | $160 |
| Cumberland Pharmaceuticals, Inc. | 10 | $146 |
| Nevro Corp. | 2 | $132 |
| Alnylam Pharmaceuticals Inc. | 1 | $125 |
| Acadia Pharmaceuticals Inc | 1 | $125 |
| Organon | 1 | $124 |
| Ultragenyx Pharmaceutical Inc. | 1 | $124 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $117 |
| Regeneron Healthcare Solutions, Inc. | 1 | $112 |
| Novo Nordisk | 1 | $96 |
| Pharming Healthcare, Inc. | 1 | $94 |
| Kyowa Kirin, Inc. | 1 | $84 |
| Sanofi-aventis U.S. LLC | 4 | $77 |
| Seqirus USA Inc | 2 | $40 |
| Sobi, Inc | 1 | $28 |
| Cipher Pharmaceuticals US LLC | 1 | $23 |
| Genentech USA, Inc. | 1 | $16 |
| Tris Pharma Inc | 1 | $16 |
| Corium, LLC | 3 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$23,997 in reported general payments places this provider in the 95th percentile of 5,361 pediatrics providers in Texas.
Other pediatrics in Houston
- Pedro PiedraHouston$729K
- Vernon SuttonHouston$90K
- Carlos BacinoHouston$53K
- Farida AbidHouston$50K
- Lindsay CameronHouston$32K
- Juan Torres SanchezHouston$31K
- Raegan HuntHouston$23K
- Michael PickettHouston$14K
- Lara LeonhardtHouston$10K
- Autumn AtkinsonHouston$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.